Microbix Biosystems Inc. (MBX.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
At close: 03:40PM EST
Currency in CAD
Valuation Measures4
| Market Cap (intraday) | 96.18M |
| Enterprise Value | 93.92M |
| Trailing P/E | 28.46 |
| Forward P/E | 18.48 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.64 |
| Price/Book (mrq) | 5.18 |
| Enterprise Value/Revenue | 5.05 |
| Enterprise Value/EBITDA | 16.60 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | 39.22% |
| S&P500 52-Week Change 3 | 16.48% |
| 52 Week High 3 | 0.8700 |
| 52 Week Low 3 | 0.4400 |
| 50-Day Moving Average 3 | 0.7300 |
| 200-Day Moving Average 3 | 0.6441 |
Share Statistics
| Avg Vol (3 month) 3 | 86.61k |
| Avg Vol (10 day) 3 | 81.61k |
| Shares Outstanding 5 | 129.97M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 111.51M |
| % Held by Insiders 1 | 10.48% |
| % Held by Institutions 1 | 2.18% |
| Shares Short (Jan. 13, 2022) 4 | 8.44k |
| Short Ratio (Jan. 13, 2022) 4 | 0.08 |
| Short % of Float (Jan. 13, 2022) 4 | N/A |
| Short % of Shares Outstanding (Jan. 13, 2022) 4 | 0.01% |
| Shares Short (prior month Dec. 14, 2021) 4 | 10.76k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Sep. 01, 1999 |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Sep. 29, 2021 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | 17.39% |
| Operating Margin (ttm) | 26.01% |
Management Effectiveness
| Return on Assets (ttm) | 13.61% |
| Return on Equity (ttm) | 25.69% |
Income Statement
| Revenue (ttm) | 18.59M |
| Revenue Per Share (ttm) | 0.16 |
| Quarterly Revenue Growth (yoy) | 108.10% |
| Gross Profit (ttm) | 11.04M |
| EBITDA | 5.66M |
| Net Income Avi to Common (ttm) | 3.23M |
| Diluted EPS (ttm) | 0.0260 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.99M |
| Total Cash Per Share (mrq) | 0.08 |
| Total Debt (mrq) | 7.74M |
| Total Debt/Equity (mrq) | 41.68 |
| Current Ratio (mrq) | 3.68 |
| Book Value Per Share (mrq) | 0.14 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.11M |
| Levered Free Cash Flow (ttm) | -1.43M |
